Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by A.C. Tree
Local Treatment of ‘Oligometastases’: Wishful Thinking is Not Supported by Available Evidence - Authors' Reply
Publication History Published online: March 19, 2020Accepted: February 25, 2020; Received: February 20, 2020;
Yesterday's News is Today's Fish and Chip Paper
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Treating prostate cancer in this decade sometimes feels like working on shifting sand. Therapeutic paradigms shift at a dizzying pace, and alter the algorithms before and after the patient's current step in the pathway.
Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer
Introduction Impressive progress has been made in prostate radiotherapy over the last 20 years, largely due to enduring and meticulous effort to optimise dose, fractionation and technique. Image guidance, smaller margins and intensity-modulated radiotherapy (IMRT) have all contributed to falling side-effect rates with no detriment to prostate-specific antigen (PSA) control rates.
Stereotactic Body Radiotherapy in Metastatic Disease: The Known Unknowns and the Unknown Unknowns
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Medical reversals are many and frequent, but this should be considered a sign of progress and testament to the evidence-based medicine era that we live in. For most of us, when we were training, we were taught that there was no point irradiating the tumour(s) unless you could give a radical dose to all disease.
The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?
Statement of Search Strategies Used and Sources of Information An electronic literature search was carried out using PubMed, Medline and clinicaltrials.gov for current studies in progress. Search terms included ‘oligoprogression’, ‘oligoprogressive disease’, ‘oligometastatic disease’, ‘prostate cancer’, ‘breast cancer’, ‘non-small cell lung cancer’, ‘resistance mechanisms’ and ‘stereotactic body radiotherapy’. Only English language publications were considered.
Magnetic Resonance-guided Radiotherapy - Can We Justify More Expensive Technology?
The importance of delivering value-based healthcare is being acknowledged across the world, regardless of the underpinning funding strategy. In the UK, the National Institute for Health and Care Excellence is recognised for spearheading the integration of health economics into healthcare.
Current Issue Table of Contents
L.E. Henke, J.A. Contreras, O.L. Green, B. Cai, H. Kim, M.C. Roach, J.R. Olsen, B. Fischer-Valuck, D.F. Mullen, R. Kashani, M.A. Thomas, J. Huang, I. Zoberi, D. Yang, V. Rodriguez, J.D. Bradley, C.G. Robinson, P. Parikh, S. Mutic, J. Michalskip720–727Published online: September 6, 2018
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with A.C.
Contact A.C., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack